Skip to main content
SpringerLink
Log in

The Nociceptin/Orphanin FQ System and the Regulation of Memory

  • Chapter
  • First Online:
The Nociceptin/Orphanin FQ Peptide Receptor

Part of the book series: Handbook of Experimental Pharmacology ((HEP,volume 254))

Abstract

Nociceptin/orphanin FQ (N/OFQ) is an endogenous neuropeptide of 17 amino acids, related to opioid peptides but with its own receptor, distinct from conventional opioid receptors, the ORL1 or NOP receptor. The NOP receptor is a G protein-coupled receptor which activates Gi/o proteins and thus induces an inhibition of neuronal activity. The peptide and its receptor are widely expressed in the central nervous system with a high density of receptors in regions involved in learning and memory. This review describes the consequences of the pharmacological manipulation of the N/OFQ system by NOP receptor ligands on learning processes and on the consolidation of various types of long-term memory. We also discuss the role of endogenous N/OFQ release in the modulation of learning and memory. Finally we propose several putative neuronal mechanisms taking place at the level of the hippocampus and amygdala and possibly underlying the behavioral amnestic or promnesic effects of NOP ligands.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Adem A, Madjid N, Kahl U, Holst S, Sadek B, Sandin J, Terenius L, Ogren SO (2017) Nociceptin and the NOP receptor in aversive learning in mice. Eur Neuropsychopharmacol 27:1298–1307

    Article  PubMed  CAS  Google Scholar 

  • Alberini CM, Ledoux JE (2013) Memory reconsolidation. Curr Biol 23:R746–R750

    Article  PubMed  CAS  Google Scholar 

  • Alder J, Kallman S, Palmieri A, Khadim F, Ayer JJ, Kumar S, Tsung K, Grinberg I, Thakker-Varia S (2013) Neuropeptide orphanin FQ inhibits dendritic morphogenesis through activation of RhoA. Dev Neurobiol 73:769–784

    Article  PubMed  CAS  Google Scholar 

  • Andero R (2015) Nociceptin and the nociceptin receptor in learning and memory. Prog Neuro-Psychopharmacol Biol Psychiatry 62:45–50

    Article  CAS  Google Scholar 

  • Andero R, Brothers SP, Jovanovic T, Chen YT, Salah-Uddin H, Cameron M, Bannister TD, Almli L, Stevens JS, Bradley B, Binder EB, Wahlestedt C, Ressler KJ (2013) Amygdala-dependent fear is regulated by Oprl1 in mice and humans with PTSD. Sci Transl Med 5:188ra73

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Asth L, Correia N, Lobao-Soares B, De Lima TC, Guerrini R, Calo G, Soares-Rachetti VP, Gavioli EC (2015) Nociceptin/orphanin FQ induces simultaneously anxiolytic and amnesic effects in the mouse elevated T-maze task. Naunyn Schmiedebergs Arch Pharmacol 388:33–41

    Article  PubMed  CAS  Google Scholar 

  • Berthele A, Platzer S, Dworzak D, Schadrack J, Mahal B, Buttner A, Assmus HP, Wurster K, Zieglgansberger W, Conrad B, Tolle TR (2003) [3H]-nociceptin ligand-binding and nociceptin opioid receptor mrna expression in the human brain. Neuroscience 121:629–640

    Article  PubMed  CAS  Google Scholar 

  • Bongsebandhu-phubhakdi S, Manabe T (2007) The neuropeptide nociceptin is a synaptically released endogenous inhibitor of hippocampal long-term potentiation. J Neurosci 27:4850–4858

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  • Bramham CR, Sarvey JM (1996) Endogenous activation of mu and delta-1 opioid receptors is required for long-term potentiation induction in the lateral perforant path: dependence on GABAergic inhibition. J Neurosci 16:8123–8131

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  • Briant JA, Nielsen DA, Proudnikov D, Londono D, Ho A, Ott J, Kreek MJ (2010) Evidence for association of two variants of the nociceptin/orphanin FQ receptor gene OPRL1 with vulnerability to develop opiate addiction in Caucasians. Psychiatr Genet 20:65–72

    Article  PubMed  Google Scholar 

  • Bridge KE, Wainwright A, Reilly K, Oliver KR (2003) Autoradiographic localization of (125)i[Tyr(14)] nociceptin/orphanin FQ binding sites in macaque primate CNS. Neuroscience 118:513–523

    Article  PubMed  CAS  Google Scholar 

  • Calo G, Guerrini R, Bigoni R, Rizzi A, Marzola G, Okawa H, Bianchi C, Lambert DG, Salvadori S, Regoli D (2000) Characterization of [Nphe(1)]nociceptin(1-13)NH(2), a new selective nociceptin receptor antagonist. Br J Pharmacol 129:1183–1193

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Calo G, Rizzi A, Rizzi D, Bigoni R, Guerrini R, Marzola G, Marti M, McDonald J, Morari M, Lambert DG, Salvadori S, Regoli D (2002) [Nphe1,Arg14,Lys15]nociceptin-NH2, a novel potent and selective antagonist of the nociceptin/orphanin FQ receptor. Br J Pharmacol 136:303–311

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Cavallini S, Marino S, Beani L, Bianchi C, Siniscalchi A (2003) Nociceptin inhibition of acetylcholine efflux from different brain areas. Neuroreport 14:2167–2170

    Article  PubMed  CAS  Google Scholar 

  • Chen YL, Li AH, Yeh TH, Chou AH, Wang HL (2009) Nocistatin and nociceptin exert opposite effects on the excitability of central amygdala nucleus-periaqueductal gray projection neurons. Mol Cell Neurosci 40:76–88

    Article  PubMed  CAS  Google Scholar 

  • Di Giannuario A, Pieretti S, Catalani A, Loizzo A (1999) Orphanin FQ reduces morphine-induced dopamine release in the nucleus accumbens: a microdialysis study in rats. Neurosci Lett 272:183–186

    Article  PubMed  Google Scholar 

  • Ferrari F, Malfacini D, Journigan BV, Bird MF, Guerrini R, Lambert DG, Calo G, Zaveri NT (2017) In vitro pharmacological characterization of a novel unbiased NOP receptor-selective nonpeptide agonist AT-403. Pharmacol Res Perspect 5(4)

    Article  CAS  Google Scholar 

  • Fornari RV, Soares JC, Ferreira TL, Moreira KM, Oliveira MG (2008) Effects of nociceptin/orphanin FQ in the acquisition of contextual and tone fear conditioning in rats. Behav Neurosci 122:98–106

    Article  PubMed  CAS  Google Scholar 

  • Fulford AJ (2015) Endogenous nociceptin system involvement in stress responses and anxiety behavior. Vitam Horm 97:267–293

    Article  PubMed  CAS  Google Scholar 

  • Gavioli EC, Calo G (2013) Nociceptin/orphanin FQ receptor antagonists as innovative antidepressant drugs. Pharmacol Ther 140:10–25

    Article  PubMed  CAS  Google Scholar 

  • Goeldner C, Reiss D, Wichmann J, Kieffer BL, Ouagazzal AM (2009) Activation of nociceptin opioid peptide (NOP) receptor impairs contextual fear learning in mice through glutamatergic mechanisms. Neurobiol Learn Mem 91:393–401

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Goeldner C, Reiss D, Wichmann J, Meziane H, Kieffer BL, Ouagazzal AM (2008) Nociceptin receptor impairs recognition memory via interaction with NMDA receptor-dependent mitogen-activated protein kinase/extracellular signal-regulated kinase signaling in the hippocampus. J Neurosci 28:2190–2198

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  • Gutierrez R, Leff P, Romo-Parra H, Acevedo R, Anton B (2001) Orphanin-FQ/nociceptin inhibits kindling epileptogenesis and enhances hippocampal feed-forward inhibition. Neuroscience 105:325–333

    Article  PubMed  CAS  Google Scholar 

  • Higgins GA, Kew JN, Richards JG, Takeshima H, Jenck F, Adam G, Wichmann J, Kemp JA, Grottick AJ (2002) A combined pharmacological and genetic approach to investigate the role of orphanin FQ in learning and memory. Eur J Neurosci 15:911–922

    Article  PubMed  CAS  Google Scholar 

  • Hiramatsu M, Inoue K (1999) Effects of nocistatin on nociceptin-induced impairment of learning and memory in mice. Eur J Pharmacol 367:151–155

    Article  PubMed  CAS  Google Scholar 

  • Hiramatsu M, Inoue K (2000) Improvement by low doses of nociceptin on scopolamine-induced impairment of learning and/or memory. Eur J Pharmacol 395:149–156

    Article  PubMed  CAS  Google Scholar 

  • Hiramatsu M, Miwa M, Hashimoto K, Kawai S, Nomura N (2008) Nociceptin/orphanin FQ reverses mecamylamine-induced learning and memory impairment as well as decrease in hippocampal acetylcholine release in the rat. Brain Res 1195:96–103

    Article  PubMed  CAS  Google Scholar 

  • Huang J, Young B, Pletcher MT, Heilig M, Wahlestedt C (2008) Association between the nociceptin receptor gene (OPRL1) single nucleotide polymorphisms and alcohol dependence. Addict Biol 13:88–94

    Article  PubMed  CAS  Google Scholar 

  • Ikeda K, Kobayashi K, Kobayashi T, Ichikawa T, Kumanishi T, Kishida H, Yano R, Manabe T (1997) Functional coupling of the nociceptin/orphanin FQ receptor with the G- protein-activated K+ (GIRK) channel. Brain Res Mol Brain Res 45:117–126

    Article  PubMed  CAS  Google Scholar 

  • Ikeda K, Watanabe M, Ichikawa T, Kobayashi T, Yano R, Kumanishi T (1998) Distribution of prepro-nociceptin/orphanin FQ mRNA and its receptor mRNA in developing and adult mouse central nervous systems. J Comp Neurol 399:139–151

    Article  PubMed  CAS  Google Scholar 

  • Jenck F, Wichmann J, Dautzenberg FM, Moreau JL, Ouagazzal AM, Martin JR, Lundstrom K, Cesura AM, Poli SM, Roever S, Kolczewski S, Adam G, Kilpatrick G (2000) A synthetic agonist at the orphanin FQ/nociceptin receptor ORL1: anxiolytic profile in the rat. Proc Natl Acad Sci U S A 97:4938–4943

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Johansen JP, Cain CK, Ostroff LE, LeDoux JE (2011) Molecular mechanisms of fear learning and memory. Cell 147:509–524

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Kallupi M, Varodayan FP, Oleata CS, Correia D, Luu G, Roberto M (2014) Nociceptin/orphanin FQ decreases glutamate transmission and blocks ethanol-induced effects in the central amygdala of naive and ethanol-dependent rats. Neuropsychopharmacology 39:1081–1092

    Article  PubMed  CAS  Google Scholar 

  • Kawahara Y, Hesselink MB, van Scharrenburg G, Westerink BH (2004) Tonic inhibition by orphanin FQ/nociceptin of noradrenaline neurotransmission in the amygdala. Eur J Pharmacol 485:197–200

    Article  PubMed  CAS  Google Scholar 

  • Kawamoto H, Ozaki S, Itoh Y, Miyaji M, Arai S, Nakashima H, Kato T, Ohta H, Iwasawa Y (1999) Discovery of the first potent and selective small molecule opioid receptor-like (ORL1) antagonist: 1-[(3R,4R)-1-cyclooctylmethyl-3- hydroxymethyl-4-piperidyl]-3-ethyl-1, 3-dihydro-2H-benzimidazol-2-one (J-113397). J Med Chem 42:5061–5063

    Article  PubMed  CAS  Google Scholar 

  • Knoflach F, Reinscheid RK, Civelli O, Kemp JA (1996) Modulation of voltage-gated calcium channels by orphanin FQ in freshly dissociated hippocampal neurons. J Neurosci 16:6657–6664

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  • Koster A, Montkowski A, Schulz S, Stube EM, Knaudt K, Jenck F, Moreau JL, Nothacker HP, Civelli O, Reinscheid RK (1999) Targeted disruption of the orphanin FQ/nociceptin gene increases stress susceptibility and impairs stress adaptation in mice. Proc Natl Acad Sci U S A 96:10444–10449

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Kuzmin A, Madjid N, Johansson B, Terenius L, Ogren SO (2009) The nociceptin system and hippocampal cognition in mice: a pharmacological and genetic analysis. Brain Res 1305(Suppl):S7–S19

    Article  PubMed  CAS  Google Scholar 

  • Lambert DG (2008) The nociceptin/orphanin FQ receptor: a target with broad therapeutic potential. Nat Rev Drug Discov 7:694–710

    Article  PubMed  CAS  Google Scholar 

  • Liu EH, Lee TL, Nishiuchi Y, Kimura T, Tachibana S (2007) Nocistatin and its derivatives antagonize the impairment of short-term acquisition induced by nociceptin. Neurosci Lett 416:155–159

    Article  PubMed  CAS  Google Scholar 

  • Lutfy K, Do T, Maidment NT (2001) Orphanin FQ/nociceptin attenuates motor stimulation and changes in nucleus accumbens extracellular dopamine induced by cocaine in rats. Psychopharmacology 154:1–7

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Lutz PE, Zhou Y, Labbe A, Mechawar N, Turecki G (2015) Decreased expression of nociceptin/orphanin FQ in the dorsal anterior cingulate cortex of suicides. Eur Neuropsychopharmacol 25:2008–2014

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Madamba SG, Schweitzer P, Siggins GR (1999) Nociceptin augments K(+) currents in hippocampal CA1 neurons by both ORL-1 and opiate receptor mechanisms. J Neurophysiol 82:1776–1785

    Article  PubMed  CAS  Google Scholar 

  • Mamiya T, Noda Y, Nishi M, Takeshima H, Nabeshima T (1998) Enhancement of spatial attention in nociceptin/orphanin FQ receptor- knockout mice. Brain Res 783:236–240

    Article  PubMed  CAS  Google Scholar 

  • Mamiya T, Noda Y, Nishi M, Takeshima H, Nabeshima T (1999) Nociceptin system plays a role in the memory retention: involvement of naloxone benzoylhydrazone binding sites. Neuroreport 10:1171–1175

    Article  PubMed  CAS  Google Scholar 

  • Mamiya T, Yamada K, Miyamoto Y, Konig N, Watanabe Y, Noda Y, Nabeshima T (2003) Neuronal mechanism of nociceptin-induced modulation of learning and memory: involvement of N-methyl-D-aspartate receptors. Mol Psychiatry 8:752–765

    Article  PubMed  CAS  Google Scholar 

  • Manabe T, Noda Y, Mamiya T, Katagiri H, Houtani T, Nishi M, Noda T, Takahashi T, Sugimoto T, Nabeshima T, Takeshima H (1998) Facilitation of long-term potentiation and memory in mice lacking nociceptin receptors. Nature 394:577–581

    Article  PubMed  CAS  Google Scholar 

  • Marin-Burgin A, Schinder AF (2012) Requirement of adult-born neurons for hippocampus-dependent learning. Behav Brain Res 227:391–399

    Article  PubMed  Google Scholar 

  • Meis S, Pape HC (1998) Postsynaptic mechanisms underlying responsiveness of amygdaloid neurons to nociceptin/orphanin FQ. J Neurosci 18:8133–8144

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  • Meis S, Pape HC (2001) Control of glutamate and GABA release by nociceptin/orphanin FQ in the rat lateral amygdala. J Physiol 532:701–712

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Meunier JC, Mollereau C, Toll L, Suaudeau C, Moisand C, Alvinerie P, Butour JL, Guillemot JC, Ferrara P, Monsarrat B et al (1995) Isolation and structure of the endogenous agonist of opioid receptor- like ORL1 receptor. Nature 377:532–535

    Article  CAS  PubMed  Google Scholar 

  • Milton AL, Everitt BJ (2012) The persistence of maladaptive memory: addiction, drug memories and anti-relapse treatments. Neurosci Biobehav Rev 36:1119–1139

    Article  PubMed  Google Scholar 

  • Miwa M, Shinki C, Uchida S, Hiramatsu M (2009) Distinct effects of nociceptin analogs on scopolamine-induced memory impairment in mice. Eur J Pharmacol 602:328–333

    Article  PubMed  CAS  Google Scholar 

  • Miwa M, Uchida S, Horiba F, Takeshima H, Nabeshima T, Hiramatsu M (2010) Nociceptin and its metabolite attenuate U0126-induced memory impairment through a nociceptin opioid peptide (NOP) receptor-independent mechanism. Neurobiol Learn Mem 93:396–405

    Article  PubMed  CAS  Google Scholar 

  • Mollereau C, Mouledous L (2000) Tissue distribution of the opioid receptor-like (ORL1) receptor. Peptides 21:907–917

    Article  PubMed  CAS  Google Scholar 

  • Mollereau C, Parmentier M, Mailleux P, Butour JL, Moisand C, Chalon P, Caput D, Vassart G, Meunier JC (1994) ORL1, a novel member of the opioid receptor family. Cloning, functional expression and localization. FEBS Lett 341:33–38

    Article  CAS  PubMed  Google Scholar 

  • Mollereau C, Simons MJ, Soularue P, Liners F, Vassart G, Meunier JC, Parmentier M (1996) Structure, tissue distribution, and chromosomal localization of the prepronociceptin gene. Proc Natl Acad Sci U S A 93:8666–8670

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Nader K (2015) Reconsolidation and the dynamic nature of memory. Cold Spring Harb Perspect Biol 7:a021782

    Article  PubMed  PubMed Central  Google Scholar 

  • Nagai J, Kurokawa M, Takeshima H, Kieffer BL, Ueda H (2007) Circadian-dependent learning and memory enhancement in nociceptin receptor-deficient mice with a novel KUROBOX apparatus using stress-free positive cue task. J Pharmacol Exp Ther 321:195–201

    Article  PubMed  CAS  Google Scholar 

  • Neal CR Jr, Mansour A, Reinscheid R, Nothacker HP, Civelli O, Akil H, Watson SJ Jr (1999a) Opioid receptor-like (ORL1) receptor distribution in the rat central nervous system: comparison of ORL1 receptor mRNA expression with (125)I- [(14)Tyr]-orphanin FQ binding. J Comp Neurol 412:563–605

    Article  CAS  PubMed  Google Scholar 

  • Neal CR Jr, Mansour A, Reinscheid R, Nothacker HP, Civelli O, Watson SJ Jr (1999b) Localization of orphanin FQ (nociceptin) peptide and messenger RNA in the central nervous system of the rat. J Comp Neurol 406:503–547

    Article  CAS  PubMed  Google Scholar 

  • New DC, Wong YH (2002) The ORL1 receptor: molecular pharmacology and signalling mechanisms. Neurosignals 11:197–212

    Article  PubMed  CAS  Google Scholar 

  • Noda Y, Mamiya T, Manabe T, Nishi M, Takeshima H, Nabeshima T (2000) Role of nociceptin systems in learning and memory. Peptides 21:1063–1069

    Article  PubMed  CAS  Google Scholar 

  • Ouagazzal AM (2015) Nociceptin/orphanin-FQ modulation of learning and memory. Vitam Horm 97:323–345

    Article  CAS  Google Scholar 

  • Post A, Smart TS, Krikke-Workel J, Dawson GR, Harmer CJ, Browning M, Jackson K, Kakar R, Mohs R, Statnick M, Wafford K, McCarthy A, Barth V, Witkin JM (2016) A selective nociceptin receptor antagonist to treat depression: evidence from preclinical and clinical studies. Neuropsychopharmacology 41:1803–1812

    Article  PubMed  CAS  Google Scholar 

  • Redrobe JP, Calo G, Guerrini R, Regoli D, Quirion R (2000) [Nphe(1)]-Nociceptin (1-13)-NH(2), a nociceptin receptor antagonist, reverses nociceptin-induced spatial memory impairments in the Morris water maze task in rats. Br J Pharmacol 131:1379–1384

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Reinscheid RK, Nothacker H, Civelli O (2000) The orphanin FQ/nociceptin gene: structure, tissue distribution of expression and functional implications obtained from knockout mice. Peptides 21:901–906

    Article  PubMed  CAS  Google Scholar 

  • Reinscheid RK, Nothacker HP, Bourson A, Ardati A, Henningsen RA, Bunzow JR, Grandy DK, Langen H, Monsma FJ Jr, Civelli O (1995) Orphanin FQ: a neuropeptide that activates an opioidlike G protein- coupled receptor. Science 270:792–794

    Article  PubMed  CAS  Google Scholar 

  • Reiss D, Prinssen EP, Wichmann J, Kieffer BL, Ouagazzal AM (2012) The nociceptin orphanin FQ peptide receptor agonist, Ro64-6198, impairs recognition memory formation through interaction with glutamatergic but not cholinergic receptor antagonists. Neurobiol Learn Mem 98:254–260

    Article  PubMed  CAS  Google Scholar 

  • Rekik K, Faria Da Silva R, Colom M, Pacifico S, Zaveri NT, Calo G, Rampon C, Frances B, Mouledous L (2017) Activation of nociceptin/orphanin FQ receptors inhibits contextual fear memory reconsolidation. Neuropharmacology 125:39–49

    Article  CAS  PubMed  Google Scholar 

  • Ring RH, Alder J, Fennell M, Kouranova E, Black IB, Thakker-Varia S (2006) Transcriptional profiling of brain-derived-neurotrophic factor-induced neuronal plasticity: a novel role for nociceptin in hippocampal neurite outgrowth. J Neurobiol 66:361–377

    Article  PubMed  CAS  Google Scholar 

  • Roberto M, Siggins GR (2006) Nociceptin/orphanin FQ presynaptically decreases GABAergic transmission and blocks the ethanol-induced increase of GABA release in central amygdala. Proc Natl Acad Sci U S A 103:9715–9720

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Roozendaal B, Lengvilas R, McGaugh JL, Civelli O, Reinscheid RK (2007) Orphanin FQ/nociceptin interacts with the basolateral amygdala noradrenergic system in memory consolidation. Learn Mem 14:29–35

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Sandin J, Georgieva J, Schott PA, Ogren SO, Terenius L (1997) Nociceptin/orphanin FQ microinjected into hippocampus impairs spatial learning in rats. Eur J Neurosci 9:194–197

    Article  CAS  PubMed  Google Scholar 

  • Sandin J, Ogren SO, Terenius L (2004) Nociceptin/orphanin FQ modulates spatial learning via ORL-1 receptors in the dorsal hippocampus of the rat. Brain Res 997:222–233

    Article  PubMed  CAS  Google Scholar 

  • Schlicker E, Morari M (2000) Nociceptin/orphanin FQ and neurotransmitter release in the central nervous system. Peptides 21:1023–1029

    Article  CAS  PubMed  Google Scholar 

  • Tallent MK, Madamba SG, Siggins GR (2001) Nociceptin reduces epileptiform events in CA3 hippocampus via presynaptic and postsynaptic mechanisms. J Neurosci 21:6940–6948

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Taverna FA, Georgiou J, McDonald RJ, Hong NS, Kraev A, Salter MW, Takeshima H, Muller RU, Roder JC (2005) Defective place cell activity in nociceptin receptor knockout mice with elevated NMDA receptor-dependent long-term potentiation. J Physiol 565:579–591

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Toll L, Bruchas MR, Calo G, Cox BM, Zaveri NT (2016) Nociceptin/orphanin FQ receptor structure, signaling, ligands, functions, and interactions with opioid systems. Pharmacol Rev 68:419–457

    Article  PubMed  PubMed Central  Google Scholar 

  • Uezu K, Sano A, Sei H, Toida K, Houtani T, Sugimoto T, Suzuki-Yamamoto T, Takeshima H, Ishimura K, Morita Y (2005) Enhanced hippocampal acetylcholine release in nociceptin-receptor knockout mice. Brain Res 1050:118–123

    Article  CAS  PubMed  Google Scholar 

  • Varty GB, Hyde LA, Hodgson RA, Lu SX, McCool MF, Kazdoba TM, Del Vecchio RA, Guthrie DH, Pond AJ, Grzelak ME, Xu X, Korfmacher WA, Tulshian D, Parker EM, Higgins GA (2005) Characterization of the nociceptin receptor (ORL-1) agonist, Ro64-6198, in tests of anxiety across multiple species. Psychopharmacology 182:132–143

    Article  PubMed  CAS  Google Scholar 

  • Vitale G, Filaferro M, Micioni Di Bonaventura MV, Ruggieri V, Cifani C, Guerrini R, Simonato M, Zucchini S (2017) Effects of [Nphe1, Arg14, Lys15] N/OFQ-NH2 (UFP-101), a potent NOP receptor antagonist, on molecular, cellular and behavioural alterations associated with chronic mild stress. J Psychopharmacol 31:691–703

    Article  PubMed  CAS  Google Scholar 

  • Wei WZ, Xie CW (1999) Orphanin FQ suppresses NMDA receptor-dependent long-term depression and depotentiation in hippocampal dentate gyrus. Learn Mem 6:467–477

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Wichmann J, Adam G, Rover S, Hennig M, Scalone M, Cesura AM, Dautzenberg FM, Jenck F (2000) Synthesis of (1S,3aS)-8-(2,3,3a,4,5, 6-hexahydro-1H-phenalen-1-yl)-1-phenyl-1,3,8-triaza-spiro[4. 5]decan-4-one, a potent and selective orphanin FQ (OFQ) receptor agonist with anxiolytic-like properties. Eur J Med Chem 35:839–851

    Article  PubMed  CAS  Google Scholar 

  • Witkin JM, Statnick MA, Rorick-Kehn LM, Pintar JE, Ansonoff M, Chen Y, Tucker RC, Ciccocioppo R (2014) The biology of nociceptin/orphanin FQ (N/OFQ) related to obesity, stress, anxiety, mood, and drug dependence. Pharmacol Ther 141:283–299

    Article  PubMed  CAS  Google Scholar 

  • Yu TP, Fein J, Phan T, Evans CJ, Xie CW (1997) Orphanin FQ inhibits synaptic transmission and long-term potentiation in rat hippocampus. Hippocampus 7:88–94

    Article  PubMed  CAS  Google Scholar 

  • Yu TP, Xie CW (1998) Orphanin FQ/nociceptin inhibits synaptic transmission and long-term potentiation in rat dentate gyrus through postsynaptic mechanisms. J Neurophysiol 80:1277–1284

    Article  PubMed  CAS  Google Scholar 

  • Zaveri N (2003) Peptide and nonpeptide ligands for the nociceptin/orphanin FQ receptor ORL1: research tools and potential therapeutic agents. Life Sci 73:663–678

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Zaveri NT (2011) The nociceptin/orphanin FQ receptor (NOP) as a target for drug abuse medications. Curr Top Med Chem 11:1151–1156

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Zaveri NT (2016) Nociceptin opioid receptor (NOP) as a therapeutic target: progress in translation from preclinical research to clinical utility. J Med Chem 59:7011–7028

    Article  PubMed  PubMed Central  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Research Center on Animal Cognition (CRCA), Center for Integrative Biology (CBI), Toulouse University, CNRS, UPS, Toulouse, France

    Lionel Moulédous

Authors
  1. Lionel Moulédous
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Lionel Moulédous .

Editor information

Editors and Affiliations

  1. Department of Physiology and Pharmacology, Wake Forest University, School of Medicine, Winston-Salem, NC, USA

    Mei-Chuan Ko

  2. Department of Medical Sciences, Section of Pharmacology, University of Ferrara, Ferrara, Italy

    Girolamo Caló

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Moulédous, L. (2018). The Nociceptin/Orphanin FQ System and the Regulation of Memory. In: Ko, MC., Caló, G. (eds) The Nociceptin/Orphanin FQ Peptide Receptor. Handbook of Experimental Pharmacology, vol 254. Springer, Cham. https://doi.org/10.1007/164_2018_185

Download citation

Publish with us

Policies and ethics

Search

Navigation